EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

A Clinical Study on the Efficacy of Acupuncture Treatment in Essential Hypertension: Protocol for Randomized Controlled Trial

Xiaomin Hao iD, Lili Zhang iD, Yu Gong iD, Jun Wang iD, Weilan Qin iD, Xudong Zhang iD, Qiulei Guo iD, Meng Xu iD, Taotao Lv iD, Yan Guo iD, Yu Liu iD, Jipeng Liu iD and 2 more

JMIR Research Protocols · 2025-05-23 · 14 · e71850

DOI: 10.2196/71850 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2025-05-23. Written by Xiaomin Hao and 13 co-authors. Institution: Department of Acupuncture and Moxibustion, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China. Major MEDLINE topics: Acupuncture Therapy, Essential Hypertension. Cited 3 times so far (Crossref); 51 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Primary hypertension represents a significant global public health issue and is a major risk factor for severe cardiovascular disease complications. Previous research has indicated that acupuncture, as a relatively safe therapeutic approach, effectively reduces blood pressure and alleviates clinical symptoms.

Objective

This study aims to assess the clinical efficacy and safety of the “HuoXueSanFeng” acupuncture technique in patients with essential hypertension.

Methods

This investigation is designed as a multicenter, randomized, single-blind, sham-controlled clinical trial. A total of 228 participants with essential hypertension will be recruited from 5 tertiary hospitals in China. Participants will be randomly allocated to either the acupuncture group or the sham acupuncture group in a 1:1 ratio. Each participant will undergo treatment 3 times per week over a 6-week period, amounting to 18 sessions in total. Follow-up assessments will be conducted at 1, 2, and 4 weeks post treatment. The primary outcome measures include 24-hour ambulatory blood pressure and immediate in-office blood pressure readings. Secondary outcome measures included the Dizziness Handicap Inventory, the Headache Impact Test-6, and the Pittsburgh Sleep Quality Index. In addition, any adverse events will be documented throughout the study to assess safety.

Results

This study was registered with the China Clinical Trial Registration Center on May 23, 2024. Data collection commenced in July 2024 and is anticipated to conclude in June 2025. Currently, the study is in the data collection phase, with 27 participants recruited, and data analysis has yet to be conducted. The findings of this study are expected to be submitted for publication in November 2025.

Conclusions

The outcomes of this study are anticipated to further elucidate the benefits of acupuncture in reducing blood pressure and to provide more robust evidence for the treatment of essential hypertension using the “HuoXueSanFeng” acupuncture method. Trial Registration Chinese Clinical Trial Registry ChiCTR2400084696; https://www.chictr.org.cn/showprojEN.html?proj=229194 International Registered Report Identifier (IRRID) DERR1-10.2196/71850

Subjects

MeSH terms (MEDLINE)

Acupuncture TherapyEssential HypertensionAdultAgedFemaleHumansMaleMiddle AgedBlood PressureChinaRandomized Controlled Trials as TopicSingle-Blind MethodTreatment OutcomeMulticenter Studies as Topic

Author keywords

acupuncturehypertensionrandomized controlled trialsham acupuncturestudy protocol

Authors and institutions

  • Department of Acupuncture and Moxibustion, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
  • National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • Department of Chinese Medicine, Beijing Jishuitan Hospital, Beijing, China.
  • Department of Rehabilitation, Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.

ORCID profiles: Xiaomin Hao, Lili Zhang, Yu Gong, Jun Wang, Weilan Qin, Xudong Zhang, Qiulei Guo, Meng Xu, Taotao Lv, Yan Guo, Yu Liu, Jipeng Liu, Bingnan Yue, Qingguo Liu

Cite

APA

Hao, X., Zhang, L., Gong, Y., Wang, J., Qin, W., Zhang, X., Guo, Q., Xu, M., Lv, T., Guo, Y., Liu, Y., Liu, J., Yue, B., & Liu, Q. (2025). A Clinical Study on the Efficacy of Acupuncture Treatment in Essential Hypertension: Protocol for Randomized Controlled Trial. JMIR Research Protocols, 14, e71850. https://doi.org/10.2196/71850

Vancouver

Hao X, Zhang L, Gong Y, Wang J, Qin W, Zhang X, et al. A Clinical Study on the Efficacy of Acupuncture Treatment in Essential Hypertension: Protocol for Randomized Controlled Trial. JMIR Research Protocols. 2025;14:e71850. doi:10.2196/71850

BibTeX
@article{Hao2025,
  author = {Hao, Xiaomin and Zhang, Lili and Gong, Yu and Wang, Jun and Qin, Weilan and Zhang, Xudong and Guo, Qiulei and Xu, Meng and Lv, Taotao and Guo, Yan and Liu, Yu and Liu, Jipeng and Yue, Bingnan and Liu, Qingguo},
  title = {A Clinical Study on the Efficacy of Acupuncture Treatment in Essential Hypertension: Protocol for Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  volume = {14},
  pages = {e71850},
  doi = {10.2196/71850}
}
Start for free →